![Michel Gardet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michel Gardet is currently a Director at Phagenesis Ltd. He was formerly a Director at Glycom A and Global Head-Business Operations at Nestle Health Science SA.
Postes actifs de Michel Gardet
| Sociétés | Poste | Début |
|---|---|---|
Phagenesis Ltd.
 Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Directeur/Membre du Conseil | - |
Anciens postes connus de Michel Gardet
| Sociétés | Poste | Fin |
|---|---|---|
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Directeur des opérations | - |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
Phagenesis Ltd.
Phagenesis Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapies to treat patients suffering from neurogenic dysphagia | Health Technology |
Nestle Health Science SA
Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Manufactures nutritional and supplement health products | Health Technology |
